JNJ vs TRON · P/E 17, rev $49.37B vs rev $4.7M
Johnson & Johnson (JNJ) versus Tron Inc. (TRON) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Tron Inc. (TRON) is a leisure company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported TRON revenue for 2025-12-31 was $4.7M. Net income was -$16.8M. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. TRON currently screens at market cap $868.1M.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. TRON currently screens at market cap $868.1M.
Not investment advice. Open the JNJ and TRON stock pages for the full models.
Not investment advice.